Wedbush Downgrades Fate Therapeutics (FATE) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.09 +0.02 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.07 | 52 Week High | $4.76 | |||
| Open | $2.04 | 52 Week Low | $1.46 | |||
| Day High | $2.13 | P/E | N/A | |||
| Day Low | $2.04 | EPS | $-1.91 | |||
| Volume | 177,836 | |||||
